- The Digital Asset Daily
- Posts
- AI Passed Its Biggest Drug Test Yet
AI Passed Its Biggest Drug Test Yet
This blue-chip pharma stock gained a year’s worth of returns before lunch.
I’m only 32. That’s young enough that I’m supposed to feel like time is on my side. But after the health scares I had in the last two years, I stopped feeling that way.
I was waking up in the middle of the night gasping for air. It felt like my throat was closing and I was breathing through a straw.
Doctors couldn’t figure out why.
I had an upper endoscopy. I had tubes stuck down my nose four times. Medication helped at first, but then the problem came back.
I’m feeling much better now. But getting there meant taking three daily medications, eliminating acidic foods and drinks, and eventually discovering that I’m very allergic to some of the most common trees in South Florida.
It took me eight months, a half dozen doctors, and $10,000 to figure that out.
I was fortunate enough to have the money to keep looking. Not long before my health problems started, I’d made $1 million in the crypto markets in about 12 months. I was ecstatic. I felt like years of due diligence and determination had paid off.
Then it became hard for me to breathe. Suddenly, the money didn’t feel nearly as important. I was going to bed wondering whether I’d wake up the next morning – and whether I’d even be around long enough to enjoy what I’d worked so hard to build.
My point is, money only gets you so far. You can see more specialists and run more tests. You still can’t buy a treatment that medicine hasn’t invented yet.
That’s what makes last month’s breakthrough so important.
Medicine Crossed a New Line